Glenmark Pharmaceuticals
today said it has issued a voluntary nationwide recall in the US for
seven lots of its oral contraceptive Norgestimate and Ethinyl Estradiol
tablets due to a packaging error.
The recall is issued by the company's US arm Glenmark Generics Inc for tablets in strengths of 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg.
"The recall is being implemented because of a packaging error, where select blisters were rotated 180 degrees within the card, reversing the weekly tablet orientation and making the lot number and expiry date visible only on the outer pouch," it added.
The recall is issued by the company's US arm Glenmark Generics Inc for tablets in strengths of 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg.
"The recall is being implemented because of a packaging error, where select blisters were rotated 180 degrees within the card, reversing the weekly tablet orientation and making the lot number and expiry date visible only on the outer pouch," it added.
No comments:
Post a Comment